A randomized phase II study of pivanex and docetaxel compared to docetaxel monotherapy in patients with previously treated advanced NSCLC

被引：1
|
作者：
Raghunadharao, D
Koralewski, P
Serwatowski, P
Gruszfeld, A
Lakshmaiah, K
Szczesna, A
Savin, M
Yen, K
Bhatnagar, A
Green, M
机构：
[1] Nizams Inst Med Sci, Hyderabad, Andhra Pradesh, India
[2] Szpital Specjalistyczny Rydygiera, Krakow, Poland
[3] Szpital Specjalistyczny Alfreda, Szczecin, Poland
[4] Warminsko Mazurskie Ctr Onkol, Olsztyn, Poland
[5] Kidwai Mem Inst Oncol, Bangalore, Karnataka, India
[6] Mazawieckie Ctr Leczenia, Otwock, Poland
[7] Texas Canc Ctr Med City, Dallas, TX USA
[8] Tita Pharmaceut Inc, San Francisco, CA USA
[9] Med Univ S Carolina, Charleston, SC 29425 USA
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)81053-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S265 / S265
页数：1
相关论文
共 50 条
  • [41] A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer
    Qin, Angel
    Wells, Leah
    Malhotra, Binu
    Gadgeel, Shirish
    Schneider, Bryan J.
    Ramnath, Nithya
    Rice, John D.
    Kalemkerian, Gregory P.
    CLINICAL LUNG CANCER, 2024, 25 (02) : 128 - 134
  • [42] Gefitinib versus Docetaxel for Previously Treated NSCLC-Response
    Lee, Dae Ho
    Kim, Sang-We
    CLINICAL CANCER RESEARCH, 2011, 17 (13) : 4611 - 4611
  • [43] Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
    Wu, Yi-Long
    Lu, Shun
    Cheng, Ying
    Zhou, Caicun
    Wang, Jie
    Mok, Tony
    Zhang, Li
    Tu, Hai-Yan
    Wu, Lin
    Feng, Jifeng
    Zhang, Yiping
    Luft, Alexander Valerievich
    Zhou, Jianying
    Ma, Zhiyong
    Lu, You
    Hu, Chengping
    Shi, Yuankai
    Baudelet, Christine
    Cai, Junliang
    Chang, Jianhua
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (05) : 867 - 875
  • [44] Phase II Study of Ramucirumab and Docetaxel for NSCLC Patients with Malignant Pleural Effusion
    Takemoto, S.
    Fukuda, M.
    Senju, H.
    Nakatomi, K.
    Sugasaki, N.
    Ogata, R.
    Tomono, H.
    Suyama, T.
    Shimada, M.
    Akagi, K.
    Hayashi, F.
    Gyotoku, H.
    Yamaguchi, H.
    Nagashima, S.
    Soda, H.
    Kinoshita, A.
    Mukae, H.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S496 - S496
  • [45] PRIMAL: A Phase 1b Study of PEGPH20 plus Docetaxel in Patients with Previously Treated Hyaluronan (HA)-High Advanced NSCLC
    Baumgart, Megan
    Bazhenova, Lyudmila
    Haggstrom, Daniel
    Baranda, Joaquina
    Belani, Chandra
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1465 - S1465
  • [46] Phase I study of oral nintedanib combined with docetaxel in previously treated Japanese patients with advanced non-small cell lung cancer (NSCLC)
    Okamoto, I.
    Miyazaki, M.
    Takeda, M.
    Azuma, K.
    Hayashi, H.
    Seto, T.
    Konishi, K.
    Sarashina, A.
    Kaiser, R.
    Nakagawa, K.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S830 - S831
  • [47] A phase II study of tivantinib monotherapy in patients with previously treated advanced or recurrent gastric cancer
    Muro, Kei
    Ryu, Min-Hee
    Yasui, Hirofumi
    Nishina, Tomohiro
    Ryoo, Baek-Yeol
    Boku, Narikazu
    Kang, Yoon-Koo
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [48] A PHASE II STUDY OF DOCETAXEL MONOTHERAPY IN SECOND-LINE TREATMENT IN PRETREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Reza, M. S.
    Hai, M. A.
    Chowdhury, Q.
    ANNALS OF ONCOLOGY, 2008, 19 : 119 - 120
  • [49] A multicenter phase II study of the combination of gemcitabine and docetaxel in previously treated patients with small cell lung cancer
    Agelaki, S
    Veslemes, M
    Syrigos, K
    Palamidas, F
    Polyzos, A
    Papakotoulas, P
    Kentepozidis, N
    Milaki, G
    Tzanakis, N
    Kouroussis, C
    Vamvakas, L
    Georgoulias, V
    LUNG CANCER, 2004, 43 (03) : 329 - 333
  • [50] A phase II study of oxaliplatin and docetaxel in patients with advanced non-small-cell lung cancer (NSCLC)
    Raez, L
    Santos, E
    Rocha-Lima, C
    Roman, E
    Kumar, P
    Farfan, N
    Decesare, T
    Lopes, G
    Rosado, M
    Wu, J
    LUNG CANCER, 2005, 49 : S265 - S265
12345